首页> 外文期刊>Biotechnology Progress >Analytical characterization of broadly neutralizing antibody CAP256LS heavy chain clipping during manufacturing development
【24h】

Analytical characterization of broadly neutralizing antibody CAP256LS heavy chain clipping during manufacturing development

机译:Analytical characterization of broadly neutralizing antibody CAP256LS heavy chain clipping during manufacturing development

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Broadly neutralizing antibody (bNAb) CAP256‐VRC26.25 (abbreviated CAP256LS), a human IgGI monoclonal antibody targeting the V1V2 site of the HIV‐1 envelope, has demonstrated high therapeutic potential as a broadly neutralizing monoclonal antibody against HIV‐1. During the process development, a heavy chain fragmentation (clipping) was observed, that led to a relative potency reduction. In this report, we highlighted a series of process and product mitigation strategies deployed to advance this product. We have detailed how analytical characterization tools, especially the microchip reduced capillary gel electrophoresis (CGE‐SDS), played a pivotal role in identifying the development issues and in providing measurements to guide implementation of mitigation strategies.
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号